Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-25-000055
Filing Date
2025-04-03
Accepted
2025-04-03 16:23:20
Documents
100
Period of Report
2025-02-23

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20250223.htm   iXBRL 10-Q 1250875
2 EX-31.1 lfcr-20250223xexx311.htm EX-31.1 11573
3 EX-31.2 lfcr-20250223xexx312.htm EX-31.2 11193
4 EX-32.1 lfcr-20250223xexx321.htm EX-32.1 5727
5 EX-32.2 lfcr-20250223xexx322.htm EX-32.2 5604
  Complete submission text file 0001005286-25-000055.txt   8693813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20250223.xsd EX-101.SCH 60090
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20250223_cal.xml EX-101.CAL 90497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20250223_def.xml EX-101.DEF 367540
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20250223_lab.xml EX-101.LAB 849454
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20250223_pre.xml EX-101.PRE 610231
103 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20250223_htm.xml XML 1177222
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 25809840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)